These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15632056)

  • 1. The C-terminal domain of RNA polymerase II functions as a phosphorylation-dependent splicing activator in a heterologous protein.
    Millhouse S; Manley JL
    Mol Cell Biol; 2005 Jan; 25(2):533-44. PubMed ID: 15632056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.
    Zeng C; Berget SM
    Mol Cell Biol; 2000 Nov; 20(21):8290-301. PubMed ID: 11027297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.
    Emili A; Shales M; McCracken S; Xie W; Tucker PW; Kobayashi R; Blencowe BJ; Ingles CJ
    RNA; 2002 Sep; 8(9):1102-11. PubMed ID: 12358429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domain.
    Tanner S; Stagljar I; Georgiev O; Schaffner W; Bourquin JP
    Biol Chem; 1997 Jun; 378(6):565-71. PubMed ID: 9224939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).
    Koizumi J; Okamoto Y; Onogi H; Mayeda A; Krainer AR; Hagiwara M
    J Biol Chem; 1999 Apr; 274(16):11125-31. PubMed ID: 10196197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements of the RNA polymerase II C-terminal domain for reconstituting pre-mRNA 3' cleavage.
    Ryan K; Murthy KG; Kaneko S; Manley JL
    Mol Cell Biol; 2002 Mar; 22(6):1684-92. PubMed ID: 11865048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA.
    Kim E; Du L; Bregman DB; Warren SL
    J Cell Biol; 1997 Jan; 136(1):19-28. PubMed ID: 9008700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
    Cao W; Garcia-Blanco MA
    J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF.
    Okamoto Y; Onogi H; Honda R; Yasuda H; Wakabayashi T; Nimura Y; Hagiwara M
    Biochem Biophys Res Commun; 1998 Aug; 249(3):872-8. PubMed ID: 9731229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing.
    Du L; Warren SL
    J Cell Biol; 1997 Jan; 136(1):5-18. PubMed ID: 9008699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.
    Sinha R; Allemand E; Zhang Z; Karni R; Myers MP; Krainer AR
    Mol Cell Biol; 2010 Jun; 30(11):2762-74. PubMed ID: 20308322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase.
    Natalizio BJ; Robson-Dixon ND; Garcia-Blanco MA
    J Biol Chem; 2009 Mar; 284(13):8692-702. PubMed ID: 19176527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
    Ma CT; Ghosh G; Fu XD; Adams JA
    J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II.
    Bourquin JP; Stagljar I; Meier P; Moosmann P; Silke J; Baechi T; Georgiev O; Schaffner W
    Nucleic Acids Res; 1997 Jun; 25(11):2055-61. PubMed ID: 9153302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.
    Fong N; Bentley DL
    Genes Dev; 2001 Jul; 15(14):1783-95. PubMed ID: 11459828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.